Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART (CLEAR)

This study has been completed.
Massachusetts General Hospital
Monash University
University of Sydney
Aarhus University Hospital
Information provided by (Responsible Party):
University of Aarhus Identifier:
First received: September 3, 2012
Last updated: February 24, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)